Gwak GY - Search Results

1

Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study.

Sinn DH, Kang D, Guallar E, Hong YS, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. BMC Med. 2022 Jan 24;20(1):18. doi: 10.1186/s12916-021-02215-x. BMC Med. 2022. PMID: 35067226 Free PMC article.

2

Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices.

Choi YS, Lee JH, Sinn DH, Song YB, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC. Choi YS, et al. Among authors: gwak gy. J Clin Gastroenterol. 2008 Oct;42(9):974-9. doi: 10.1097/MCG.0b013e318126c154. J Clin Gastroenterol. 2008. PMID: 18528292 Clinical Trial.

3

Disease progression and the risk factor analysis for chronic hepatitis C.

Sinn DH, Paik SW, Kang P, Kil JS, Park SU, Lee SY, Song SM, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Liver Int. 2008 Dec;28(10):1363-9. doi: 10.1111/j.1478-3231.2008.01860.x. Liver Int. 2008. PMID: 18710426

4

[Natural history of gastric varices and risk factors for bleeding].

Lee CH, Lee JH, Choi YS, Paik SW, Sinn DH, Lee CY, Koh KC, Gwak GY, Choi MS, Yoo BC. Lee CH, et al. Among authors: gwak gy. Korean J Hepatol. 2008 Sep;14(3):331-41. doi: 10.3350/kjhep.2008.14.3.331. Korean J Hepatol. 2008. PMID: 18815456 Korean.

5

Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response.

Shin SR, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Shin SR, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2010 May;25(5):957-63. doi: 10.1111/j.1440-1746.2009.06176.x. J Gastroenterol Hepatol. 2010. PMID: 20546450

6

Defining virologic relapse in chronic hepatitis B.

Kim KH, Sinn DH, Yun WK, Cho HC, Lee YY, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Kim KH, et al. Among authors: gwak gy. Dig Dis Sci. 2011 Aug;56(8):2432-8. doi: 10.1007/s10620-011-1597-y. Epub 2011 Feb 12. Dig Dis Sci. 2011. PMID: 21318588

7

Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea.

Sinn DH, Shin SR, Kil JS, Kim J, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Sinn DH, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2011 Mar;26(3):469-76. doi: 10.1111/j.1440-1746.2010.06478.x. J Gastroenterol Hepatol. 2011. PMID: 21332544

8

Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian patients.

Sinn DH, Kim YJ, Lee ST, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Sinn DH, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2011 Sep;26(9):1374-9. doi: 10.1111/j.1440-1746.2011.06744.x. J Gastroenterol Hepatol. 2011. PMID: 21501223

9

Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients.

Kim YJ, Cho HC, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Kim YJ, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2012 Feb;27(2):306-12. doi: 10.1111/j.1440-1746.2011.06852.x. J Gastroenterol Hepatol. 2012. PMID: 21777281

10

Ribavirin dose and treatment outcome of Korean patients with genotype 1 chronic hepatitis C.

Sinn DH, Kim J, Shin SR, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Sinn DH, et al. Among authors: gwak gy. Hepatogastroenterology. 2012 Jan-Feb;59(113):1-6. doi: 10.5754/hge11387. Hepatogastroenterology. 2012. PMID: 21940368

11

Virological response to adefovir monotherapy and the risk of adefovir resistance.

Sinn DH, Lee HIe, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Sinn DH, et al. Among authors: gwak gy. World J Gastroenterol. 2011 Aug 14;17(30):3526-30. doi: 10.3748/wjg.v17.i30.3526. World J Gastroenterol. 2011. PMID: 21941420 Free PMC article.

12

Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.

Sinn DH, Gwak GY, Park HN, Kim JE, Min YW, Kim KM, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Am J Gastroenterol. 2012 Apr;107(4):561-7. doi: 10.1038/ajg.2011.400. Epub 2011 Nov 22. Am J Gastroenterol. 2012. PMID: 22108448

13

Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance.

Kim YJ, Paik SW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC. Kim YJ, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2012 Sep;27(9):1454-60. doi: 10.1111/j.1440-1746.2011.07050.x. J Gastroenterol Hepatol. 2012. PMID: 22168753

14

Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.

Park HN, Sinn DH, Gwak GY, Kim JE, Rhee SY, Eo SJ, Kim YJ, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Park HN, et al. Among authors: gwak gy. Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20. Liver Int. 2012. PMID: 22260521

15

Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study.

Sinn DH, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Dig Dis Sci. 2013 Mar;58(3):751-8. doi: 10.1007/s10620-012-2408-9. Epub 2012 Sep 30. Dig Dis Sci. 2013. PMID: 23053886

16

Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1.

Yi J, Gwak GY, Sinn DH, Kim YJ, Kim HN, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Yi J, et al. Among authors: gwak gy. Hepatogastroenterology. 2013 Mar-Apr;60(122):328-32. doi: 10.5754/hge12721. Hepatogastroenterology. 2013. PMID: 23241421

17

Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures.

Kim YJ, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Kim YJ, et al. Among authors: gwak gy. World J Gastroenterol. 2012 Dec 21;18(47):6996-7002. doi: 10.3748/wjg.v18.i47.6996. World J Gastroenterol. 2012. PMID: 23322999 Free PMC article. Clinical Trial.

18

Steatosis among living liver donors without evidence of fatty liver on ultrasonography: potential implications for preoperative liver biopsy.

Ahn JS, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Ahn JS, et al. Among authors: gwak gy. Transplantation. 2013 Jun 15;95(11):1404-9. doi: 10.1097/TP.0b013e31828d1588. Transplantation. 2013. PMID: 23542472

19

Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.

Sinn DH, Gwak GY, Shin JU, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. World J Gastroenterol. 2013;19(14):2256-61. doi: 10.3748/wjg.v19.i14.2256. World J Gastroenterol. 2013. PMID: 23599653 Free PMC article.

20

Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.

Sinn DH, Gwak GY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21. Atherosclerosis. 2014. PMID: 24704629

21

A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.

Shin JU, Kim KM, Shin SW, Min SY, Park SU, Sinn DH, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC, Koh KC. Shin JU, et al. Among authors: gwak gy. Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2. Dig Liver Dis. 2014. PMID: 24881853 Clinical Trial.

22

Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.

Sinn DH, Gwak GY, Cho J, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014. PLoS One. 2014. PMID: 25372403 Free PMC article. Clinical Trial.

23

Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: treatment outcome and prognostic factors.

Sohn W, Paik YH, Cho JY, Lim HY, Ahn JM, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sohn W, et al. Among authors: gwak gy. J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13. J Hepatol. 2015. PMID: 25514557

24

Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women.

Sinn DH, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Sinn DH, et al. Among authors: gwak gy. Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11. Digestion. 2015. PMID: 25677815

25

Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy.

Lee JY, Lim SH, Lee MY, Kim H, Sinn DH, Gwak GY, Choi MS, Lee JH, Jung CW, Jang JH, Kim WS, Kim SJ, Kim K. Lee JY, et al. Among authors: gwak gy. Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12. Liver Int. 2015. PMID: 25832927

26

Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.

Sinn DH, Yi J, Choi MS, Kim YJ, Gwak GY, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Hepatogastroenterology. 2015 Mar-Apr;62(138):327-32. Hepatogastroenterology. 2015. PMID: 25916058

27

Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread.

Sinn DH, Cho JY, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015. PLoS One. 2015. PMID: 25923439 Free PMC article.

28

Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.

Sinn DH, Lee J, Goo J, Kim K, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Sinn DH, et al. Among authors: gwak gy. Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3. Hepatology. 2015. PMID: 25963803

29

Incidence and risk factors for surveillance failure in patients with regular hepatocellular carcinoma surveillance.

Sinn DH, Yi J, Choi MS, Choi D, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Hepatol Int. 2013 Oct;7(4):1010-8. doi: 10.1007/s12072-013-9462-z. Epub 2013 Jul 27. Hepatol Int. 2013. PMID: 26202030

30

Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.

Kim HJ, Sinn DH, Kim NJ, Kim JH, Kim E, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Kim HJ, et al. Among authors: gwak gy. Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28. Dig Dis Sci. 2015. PMID: 26215285

31

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.

Ahn JM, Paik YH, Min SY, Cho JY, Sohn W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Ahn JM, et al. Among authors: gwak gy. Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155. Gut Liver. 2016. PMID: 26347511 Free PMC article.

32

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure.

Ha JM, Sohn W, Cho JY, Pyo JH, Choi K, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Paik YH. Ha JM, et al. Among authors: gwak gy. Clin Mol Hepatol. 2015 Sep;21(3):232-41. doi: 10.3350/cmh.2015.21.3.232. Epub 2015 Sep 30. Clin Mol Hepatol. 2015. PMID: 26523268 Free PMC article.

33

Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.

Lee J, Sinn DH, Kim JH, Gwak GY, Kim HS, Jung SH, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Lee J, et al. Among authors: gwak gy. J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16. J Korean Med Sci. 2015. PMID: 26539006 Free PMC article.

34

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.

Ahn JM, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Ahn JM, et al. Among authors: gwak gy. PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015. PLoS One. 2015. PMID: 26696302 Free PMC article. Clinical Trial.

35

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.

Sinn DH, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW. Sinn DH, et al. Among authors: gwak gy. Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578. Medicine (Baltimore). 2016. PMID: 26817915 Free PMC article.

36

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.

Kim JM, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CHD, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK. Kim JM, et al. Among authors: gwak gy. Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. Medicine (Baltimore). 2016. PMID: 26886612 Free PMC article.

37

Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial.

Yu JI, Park HC, Oh D, Noh JM, Jung SH, Kim HY, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Yu JI, et al. Among authors: gwak gy. Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Int J Hyperthermia. 2016. PMID: 26915594 Free article. Clinical Trial.

38

Kim KM, Sinn DH, Jung SH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim KM, et al. Among authors: gwak gy. Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24. Liver Int. 2016. PMID: 26936471

39

Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease.

Hong YS, Sinn DH, Gwak GY, Cho J, Kang D, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Hong YS, et al. Among authors: gwak gy. World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785. World J Gastroenterol. 2016. PMID: 27076763 Free PMC article.

40

Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.

Lee K, Sinn DH, Gwak GY, Cho HC, Jung SH, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Lee K, et al. Among authors: gwak gy. Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368. Gut Liver. 2016. PMID: 27114418 Free PMC article.

41

Corrigendum to "Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease" [Atherosclerosis 234 (2) (2014) 270-275].

Sinn DH, Gwak GY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sinn DH, et al. Among authors: gwak gy. Atherosclerosis. 2016 Jul;250:191. doi: 10.1016/j.atherosclerosis.2016.05.006. Epub 2016 May 10. Atherosclerosis. 2016. PMID: 27177847 No abstract available.

42

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma.

Kim JH, Sinn DH, Kim K, Kim H, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JH, et al. Among authors: gwak gy. Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527. Gut Liver. 2016. PMID: 27282264 Free PMC article.

43

Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.

Sinn DH, Cho SJ, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7. Gastroenterology. 2016. PMID: 27283259

44

Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.

Sohn W, Kang TW, Choi SK, Jung SH, Lee MW, Lim HK, Cho JY, Shim SG, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Rhim H, Paik YH. Sohn W, et al. Among authors: gwak gy. Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026. Oncotarget. 2016. PMID: 27329596 Free PMC article.

45

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.

Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh AM, Joh JW, Cho SK, Shin SW, Carriere KC, Ahn JH, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JY, et al. Among authors: gwak gy. Clin Mol Hepatol. 2016 Jun;22(2):250-8. doi: 10.3350/cmh.2016.0015. Epub 2016 Jun 30. Clin Mol Hepatol. 2016. PMID: 27377909 Free PMC article.

46

Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma.

Kim JH, Sinn DH, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JH, et al. Among authors: gwak gy. Dig Dis Sci. 2016 Nov;61(11):3354-3362. doi: 10.1007/s10620-016-4255-6. Epub 2016 Jul 19. Dig Dis Sci. 2016. PMID: 27435325

47

Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study.

Kim JH, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CHD, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JH, et al. Among authors: gwak gy. Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735. Medicine (Baltimore). 2016. PMID: 27583916 Free PMC article.

48

Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.

Sinn DH, Kang D, Chang Y, Ryu S, Gu S, Kim H, Seong D, Cho SJ, Yi BK, Park HD, Paik SW, Song YB, Lazo M, Lima JA, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6. Gut. 2017. PMID: 27599521

49

Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B.

Cho Y, Sinn DH, Yu SJ, Gwak GY, Kim JH, Yoo YJ, Jun DW, Kim TY, Lee HY, Cho EJ, Lee JH, Kim YJ, Yoon JH. Cho Y, et al. Among authors: gwak gy. PLoS One. 2016 Nov 15;11(11):e0165722. doi: 10.1371/journal.pone.0165722. eCollection 2016. PLoS One. 2016. PMID: 27846227 Free PMC article.

50

Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients.

Kim JH, Sinn DH, Gwak GY, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JH, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. J Gastroenterol Hepatol. 2017. PMID: 27862289

51

A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.

Sinn DH, Lee JH, Kim K, Ahn JH, Lee JH, Kim JH, Lee DH, Yoon JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Sinn DH, et al. Among authors: gwak gy. Gut Liver. 2017 Jul 15;11(4):528-534. doi: 10.5009/gnl16403. Gut Liver. 2017. PMID: 27980231 Free PMC article.

52

Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.

Kim JH, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JH, et al. Among authors: gwak gy. Hepatology. 2017 Aug;66(2):335-343. doi: 10.1002/hep.28916. Epub 2016 Dec 24. Hepatology. 2017. PMID: 28012257

53

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE.

Kim JH, Sinn DH, Shin SW, Cho SK, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS. Kim JH, et al. Among authors: gwak gy. Clin Mol Hepatol. 2017 Mar;23(1):42-50. doi: 10.3350/cmh.2016.0058. Epub 2017 Mar 7. Clin Mol Hepatol. 2017. PMID: 28263954 Free PMC article.

54

[The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].

Ko YS, Bae JH, Sinn DH, Gwak GY, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Ko YS, et al. Among authors: gwak gy. Korean J Gastroenterol. 2017 Apr 25;69(4):232-238. doi: 10.4166/kjg.2017.69.4.232. Korean J Gastroenterol. 2017. PMID: 28449425 Free article. Korean.

55

Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.

Paik N, Sinn DH, Lee JH, Oh IS, Kim JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Paik N, et al. Among authors: gwak gy. Liver Int. 2018 Jan;38(1):68-75. doi: 10.1111/liv.13489. Epub 2017 Jul 3. Liver Int. 2018. PMID: 28581248

56

Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors.

Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak GY, Heimbach JK, Kim GS. Han S, et al. Among authors: gwak gy, gwak ms. Ann Surg. 2018 Dec;268(6):1043-1050. doi: 10.1097/SLA.0000000000002318. Ann Surg. 2018. PMID: 28628564

57

Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.

Sinn DH, Min YW, Son HJ, Rhee PL, Paik SW, Hong SN, Gwak GY. Sinn DH, et al. Among authors: gwak gy. PLoS One. 2017 Jun 21;12(6):e0179480. doi: 10.1371/journal.pone.0179480. eCollection 2017. PLoS One. 2017. PMID: 28636624 Free PMC article.

58

Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.

Sinn DH, Kang D, Jang HR, Gu S, Cho SJ, Paik SW, Ryu S, Chang Y, Lazo M, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. J Hepatol. 2017 Dec;67(6):1274-1280. doi: 10.1016/j.jhep.2017.08.024. Epub 2017 Sep 20. J Hepatol. 2017. PMID: 28870674

59

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial.

Yu JI, Park HC, Jung SH, Choi C, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Sahinbas H, Paik SW. Yu JI, et al. Among authors: gwak gy. Oncotarget. 2017 Apr 13;8(32):52651-52664. doi: 10.18632/oncotarget.17072. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881759 Free PMC article.

60

Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.

Oh IS, Sinn DH, Kang TW, Lee MW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Oh IS, et al. Among authors: gwak gy. Dig Dis Sci. 2017 Nov;62(11):3235-3242. doi: 10.1007/s10620-017-4775-8. Epub 2017 Oct 5. Dig Dis Sci. 2017. PMID: 28983724

61

Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.

Min YW, Kim Y, Gwak GY, Gu S, Kang D, Cho SJ, Guallar E, Cho J, Sinn DH. Min YW, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2018 May;33(5):1053-1058. doi: 10.1111/jgh.14042. Epub 2018 Feb 15. J Gastroenterol Hepatol. 2018. PMID: 29131401

62

Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.

Kim JH, Sinn DH, Lee JH, Hyun D, Cho SK, Shin SW, Chang Y, Kim YJ, Yoon JH, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS. Kim JH, et al. Among authors: gwak gy. Dig Dis Sci. 2018 Apr;63(4):1062-1071. doi: 10.1007/s10620-018-4934-6. Epub 2018 Feb 13. Dig Dis Sci. 2018. PMID: 29442276

63

Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.

Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, Lee JH, Koh KC, Paik SW. Bae J, et al. Among authors: gwak gy. Liver Int. 2018 Aug;38(8):1442-1448. doi: 10.1111/liv.13732. Epub 2018 Mar 25. Liver Int. 2018. PMID: 29495113

64

Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study.

Jang HR, Kang D, Sinn DH, Gu S, Cho SJ, Lee JE, Huh W, Paik SW, Ryu S, Chang Y, Shafi T, Lazo M, Guallar E, Cho J, Gwak GY. Jang HR, et al. Among authors: gwak gy. Sci Rep. 2018 Mar 16;8(1):4718. doi: 10.1038/s41598-018-23014-0. Sci Rep. 2018. PMID: 29549269 Free PMC article.

65

Initial clinical outcomes of proton beam radiotherapy for hepatocellular carcinoma.

Yu JI, Yoo GS, Cho S, Jung SH, Han Y, Park S, Lee B, Kang W, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC. Yu JI, et al. Among authors: gwak gy. Radiat Oncol J. 2018 Mar;36(1):25-34. doi: 10.3857/roj.2017.00409. Epub 2018 Mar 29. Radiat Oncol J. 2018. PMID: 29580046 Free PMC article.

66

Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?

Kim KM, Kim J, Sinn DH, Kim HS, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim KM, et al. Among authors: gwak gy. Scand J Gastroenterol. 2018 Jun;53(6):727-733. doi: 10.1080/00365521.2018.1458895. Epub 2018 Apr 3. Scand J Gastroenterol. 2018. PMID: 29609485

67

Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.

Song BG, Sinn DH, Chi S, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Song BG, et al. Among authors: gwak gy. Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1447-1452. doi: 10.1097/MEG.0000000000001226. Eur J Gastroenterol Hepatol. 2018. PMID: 30063482

68

Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.

Sinn DH, Choi GS, Park HC, Kim JM, Kim H, Song KD, Kang TW, Lee MW, Rhim H, Hyun D, Cho SK, Shin SW, Jeong WK, Kim SH, Yu JI, Ha SY, Lee SJ, Lim HY, Kim K, Ahn JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Joh JW, Lim HK, Paik SW. Sinn DH, et al. Among authors: gwak gy. PLoS One. 2019 Jan 14;14(1):e0210730. doi: 10.1371/journal.pone.0210730. eCollection 2019. PLoS One. 2019. PMID: 30640924 Free PMC article.

69

Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study.

Sinn DH, Kang D, Kang M, Paik SW, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. BMC Cancer. 2019 Mar 29;19(1):286. doi: 10.1186/s12885-019-5508-5. BMC Cancer. 2019. PMID: 30922251 Free PMC article.

70

Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia.

Kim TS, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim TS, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2019 Nov;34(11):2028-2035. doi: 10.1111/jgh.14750. Epub 2019 Jul 28. J Gastroenterol Hepatol. 2019. PMID: 31157456

71

Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.

Sinn DH, Kang D, Cho SJ, Paik SW, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Eur J Endocrinol. 2019 Aug;181(2):185-192. doi: 10.1530/EJE-19-0143. Eur J Endocrinol. 2019. PMID: 31176297

72

Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea.

Kim J, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim J, et al. Among authors: gwak gy. Korean J Intern Med. 2020 Jan;35(1):65-78. doi: 10.3904/kjim.2018.040. Epub 2019 Jun 17. Korean J Intern Med. 2020. PMID: 31189301 Free PMC article.

73

Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.

Sinn DH, Kang D, Chang Y, Ryu S, Cho SJ, Paik SW, Song YB, Pastor-Barriuso R, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2020 May;35(5):833-839. doi: 10.1111/jgh.14856. Epub 2019 Oct 27. J Gastroenterol Hepatol. 2020. PMID: 31512278

74

Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study.

Sinn DH, Kang D, Cho SJ, Chang Y, Ryu S, Song YB, Paik SW, Hong YS, Zhao D, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz040. doi: 10.1210/clinem/dgz040. J Clin Endocrinol Metab. 2020. PMID: 31545359

75

Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Goh MJ, Sinn DH, Kim S, Woo SY, Cho H, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. Among authors: gwak gy. Hepatology. 2020 Jun;71(6):2023-2032. doi: 10.1002/hep.30973. Epub 2020 Feb 14. Hepatology. 2020. PMID: 31556128

76

Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.

Kim J, Chung SJ, Sinn DH, Lee KW, Park JB, Huh W, Lee JE, Jang HR, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim J, et al. Among authors: gwak gy. J Viral Hepat. 2020 Jul;27(7):739-746. doi: 10.1111/jvh.13279. Epub 2020 Feb 28. J Viral Hepat. 2020. PMID: 32057171

77

Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma.

Song BG, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Kim JM, Joh JW, Choi GS. Song BG, et al. Among authors: gwak gy. Transplant Proc. 2020 Apr;52(3):881-888. doi: 10.1016/j.transproceed.2020.01.037. Epub 2020 Feb 28. Transplant Proc. 2020. PMID: 32115240

78

Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study.

Hong CY, Sinn DH, Kang D, Paik SW, Guallar E, Cho J, Gwak GY. Hong CY, et al. Among authors: gwak gy. J Viral Hepat. 2020 Sep;27(9):896-903. doi: 10.1111/jvh.13304. Epub 2020 May 18. J Viral Hepat. 2020. PMID: 32340080

79

Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score.

Sinn DH, Kang D, Cho SJ, Paik SW, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Int J Epidemiol. 2020 Oct 1;49(5):1562-1571. doi: 10.1093/ije/dyaa089. Int J Epidemiol. 2020. PMID: 32725117

80

Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.

Oh JH, Goh MJ, Park Y, Kim J, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Paik YH. Oh JH, et al. Among authors: gwak gy. Dig Dis Sci. 2021 Aug;66(8):2816-2825. doi: 10.1007/s10620-020-06591-x. Epub 2020 Sep 8. Dig Dis Sci. 2021. PMID: 32897445

81

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients.

Kim J, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim J, et al. Among authors: gwak gy. Clin Mol Hepatol. 2020 Oct;26(4):516-528. doi: 10.3350/cmh.2020.0016. Epub 2020 Sep 11. Clin Mol Hepatol. 2020. PMID: 32911589 Free PMC article.

82

Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.

Seong G, Sinn DH, Kang W, Gwak GY, Choi MS, Lee JH, Koh KC, Woon Paik S, Paik YH. Seong G, et al. Among authors: gwak gy. Eur J Gastroenterol Hepatol. 2022 Jan 1;34(1):69-75. doi: 10.1097/MEG.0000000000001915. Eur J Gastroenterol Hepatol. 2022. PMID: 32925504

83

Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria.

Oh JH, Sinn DH, Choi GS, Kim JM, Joh JW, Kang TW, Hyun D, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS. Oh JH, et al. Among authors: gwak gy. Ann Surg Treat Res. 2020 Oct;99(4):238-246. doi: 10.4174/astr.2020.99.4.238. Epub 2020 Sep 24. Ann Surg Treat Res. 2020. PMID: 33029483 Free PMC article.

84

Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study.

Sinn DH, Kang D, Guallar E, Chang Y, Ryu S, Zhao D, Hong YS, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Am J Gastroenterol. 2021 Feb 1;116(2):329-335. doi: 10.14309/ajg.0000000000000966. Am J Gastroenterol. 2021. PMID: 33038136

85

A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients.

Song BG, Kim MJ, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Song BG, et al. Among authors: gwak gy. Dig Liver Dis. 2021 Feb;53(2):210-215. doi: 10.1016/j.dld.2020.10.030. Epub 2020 Nov 11. Dig Liver Dis. 2021. PMID: 33189588

86

Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Lee JS, Chon YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kang W, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Kim HY, Kim TH, Yoo K, Ha Y, Kim MN, Lee JH, Hwang SG, Kim SS, Cho HJ, Cheong JY, Cho SW, Park SH, Heo NY, Hong YM, Yoon KT, Cho M, Park JG, Kang MK, Park SY, Kweon YO, Tak WY, Jang SY, Sinn DH, Kim SU; Korean TACE Study Group. Lee JS, et al. Among authors: gwak gy. Yonsei Med J. 2021 Jan;62(1):12-20. doi: 10.3349/ymj.2021.62.1.12. Yonsei Med J. 2021. PMID: 33381930 Free PMC article.

87

Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal.

Song JH, Goh MJ, Park Y, Oh JH, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Song JH, et al. Among authors: gwak gy. Scand J Gastroenterol. 2021 Mar;56(3):274-280. doi: 10.1080/00365521.2020.1866063. Epub 2021 Jan 5. Scand J Gastroenterol. 2021. PMID: 33399022

88

Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance.

Park Y, Lee JH, Sinn DH, Park JY, Kim MA, Kim YJ, Yoon JH, Kim DY, Ahn SH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Park Y, et al. Among authors: gwak gy. Clin Transl Gastroenterol. 2021 Jan 11;12(1):e00290. doi: 10.14309/ctg.0000000000000290. Clin Transl Gastroenterol. 2021. PMID: 33433118 Free PMC article.

89

Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea.

Goh MJ, Oh JH, Park Y, Kim J, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. Among authors: gwak gy. Liver Cancer. 2021 Feb;10(1):52-62. doi: 10.1159/000512239. Epub 2021 Jan 8. Liver Cancer. 2021. PMID: 33708639 Free PMC article.

90

Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.

Sinn DH, Kang D, Cho SJ, Paik SW, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e529-e534. doi: 10.1097/MEG.0000000000002158. Eur J Gastroenterol Hepatol. 2021. PMID: 33867441

91

Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.

Kim JE, Sinn DH, Choi GS, Kim JM, Joh JW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JE, et al. Among authors: gwak gy. Dig Liver Dis. 2021 Aug;53(8):1004-1010. doi: 10.1016/j.dld.2021.03.030. Epub 2021 Apr 27. Dig Liver Dis. 2021. PMID: 33931340

92

Author Correction: Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study.

Jang HR, Kang D, Sinn DH, Gu S, Cho SJ, Lee JE, Huh W, Paik SW, Ryu S, Chang Y, Shafi T, Lazo M, Guallar E, Cho J, Gwak GY. Jang HR, et al. Among authors: gwak gy. Sci Rep. 2021 May 21;11(1):11139. doi: 10.1038/s41598-021-90150-5. Sci Rep. 2021. PMID: 34021223 Free PMC article. No abstract available.

93

The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.

Park Y, Sinn DH, Oh JH, Goh MJ, Kim K, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Gwak GY. Park Y, et al. Among authors: gwak gy. Hepatology. 2021 Dec;74(6):2988-2997. doi: 10.1002/hep.32034. Epub 2021 Jul 26. Hepatology. 2021. PMID: 34192367

94

Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response.

Na JE, Sinn DH, Lee JH, Jang HJ, Baek SY, Kim KA, Kang WS, Gwak GY, Paik YH, Kim YJ, Choi MS, Yoon JH, Lee JH, Koh KC, Paik SW. Na JE, et al. Among authors: gwak gy. J Viral Hepat. 2021 Oct;28(10):1392-1399. doi: 10.1111/jvh.13572. Epub 2021 Jul 20. J Viral Hepat. 2021. PMID: 34251707

95

Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.

Oh JH, Lee HW, Sinn DH, Park JY, Kim BK, Kim SU, Kim DY, Ahn SH, Kang W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Paik YH. Oh JH, et al. Among authors: gwak gy. Hepatol Int. 2021 Aug;15(4):892-900. doi: 10.1007/s12072-021-10205-7. Epub 2021 Jul 14. Hepatol Int. 2021. PMID: 34260013

96

Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.

Sinn DH, Kang D, Hong YS, Koh KC, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. PLoS One. 2021 Aug 3;16(8):e0255624. doi: 10.1371/journal.pone.0255624. eCollection 2021. PLoS One. 2021. PMID: 34343200 Free PMC article.

97

Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B.

Goh MJ, Kang W, Kim KM, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. Among authors: gwak gy. Scand J Gastroenterol. 2022 Jan;57(1):70-77. doi: 10.1080/00365521.2021.1988700. Epub 2021 Nov 3. Scand J Gastroenterol. 2022. PMID: 34731072

98

Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.

Chang JI, Sinn DH, Cho H, Kim S, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Chang JI, et al. Among authors: gwak gy. Dig Dis Sci. 2022 Sep;67(9):4565-4573. doi: 10.1007/s10620-021-07312-8. Epub 2021 Nov 20. Dig Dis Sci. 2022. PMID: 34800218

99

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.

Hong JY, Cho HJ, Sa JK, Liu X, Ha SY, Lee T, Kim H, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC, Kang TW, Rhim H, Lee SJ, Cristescu R, Lee J, Paik YH, Lim HY. Hong JY, et al. Among authors: gwak gy. Genome Med. 2022 Jan 6;14(1):1. doi: 10.1186/s13073-021-00995-8. Genome Med. 2022. PMID: 34986867 Free PMC article. Clinical Trial.

100

Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.

Goh MJ, Kang W, Jeong WK, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. Among authors: gwak gy. Sci Rep. 2022 May 10;12(1):7647. doi: 10.1038/s41598-022-11736-1. Sci Rep. 2022. PMID: 35538112 Free PMC article.

101

Changes in the prevalence of hepatitis B and metabolic abnormalities among young men in Korea.

Song BG, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Song BG, et al. Among authors: gwak gy. Korean J Intern Med. 2022 Sep;37(5):1082-1087. doi: 10.3904/kjim.2021.452. Epub 2022 May 13. Korean J Intern Med. 2022. PMID: 35569823 Free PMC article.

102

Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.

Sinn DH, Kang D, Kang M, Guallar E, Hong YS, Lee KH, Park J, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Hepatology. 2022 Dec;76(6):1746-1754. doi: 10.1002/hep.32578. Epub 2022 Jun 10. Hepatology. 2022. PMID: 35588190

103

Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis.

Yu JI, Kang W, Yoo GS, Goh MJ, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Hong JY, Lim HY, Park B, Park HC. Yu JI, et al. Among authors: gwak gy. Front Oncol. 2022 May 11;12:888755. doi: 10.3389/fonc.2022.888755. eCollection 2022. Front Oncol. 2022. PMID: 35646674 Free PMC article.

104

Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea.

Kwon TJ, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Sinn DH, Paik SW. Kwon TJ, et al. Among authors: gwak gy. Korean J Transplant. 2021 Mar 31;35(1):24-32. doi: 10.4285/kjt.20.0054. Korean J Transplant. 2021. PMID: 35769621 Free PMC article.

105

Imaging features of hepatobiliary MRI and the risk of hepatocellular carcinoma development.

Chang JI, Sinn DH, Jeong WK, Hwang JA, Won HY, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Chang JI, et al. Among authors: gwak gy. Scand J Gastroenterol. 2022 Dec;57(12):1470-1477. doi: 10.1080/00365521.2022.2093124. Epub 2022 Jul 4. Scand J Gastroenterol. 2022. PMID: 35786290

106

Reply.

Sinn DH, Kang D, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Hepatology. 2022 Dec;76(6):E121-E122. doi: 10.1002/hep.32678. Epub 2022 Aug 9. Hepatology. 2022. PMID: 35862461 No abstract available.

107

Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome.

Sinn DH, Kang D, Choi SC, Hong YS, Zhao D, Guallar E, Park Y, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1873-1880.e1. doi: 10.1016/j.cgh.2022.09.014. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152895

108

The association of non-alcoholic fatty liver disease between parents and adolescent children.

Park Y, Sinn DH, Kim K, Gwak GY. Park Y, et al. Among authors: gwak gy. Aliment Pharmacol Ther. 2023 Jan;57(2):245-252. doi: 10.1111/apt.17257. Epub 2022 Oct 21. Aliment Pharmacol Ther. 2023. PMID: 36271616

109

Reply.

Sinn DH, Kang D, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2435-2436. doi: 10.1016/j.cgh.2022.11.035. Epub 2022 Dec 9. Clin Gastroenterol Hepatol. 2023. PMID: 36503169 No abstract available.

110

Letter: hereditary role in non-alcoholic fatty liver disease - authors' reply.

Park Y, Sinn DH, Gwak GY. Park Y, et al. Among authors: gwak gy. Aliment Pharmacol Ther. 2023 Jan;57(2):275-276. doi: 10.1111/apt.17342. Aliment Pharmacol Ther. 2023. PMID: 36565003 No abstract available.

111

Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children - authors' reply.

Park Y, Sinn DH, Gwak GY. Park Y, et al. Among authors: gwak gy. Aliment Pharmacol Ther. 2023 Mar;57(6):739-740. doi: 10.1111/apt.17403. Aliment Pharmacol Ther. 2023. PMID: 36821752 No abstract available.

112

Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study.

Park Y, Sinn DH, Kim K, Gwak GY. Park Y, et al. Among authors: gwak gy. Sci Rep. 2023 Mar 23;13(1):4724. doi: 10.1038/s41598-023-31686-6. Sci Rep. 2023. PMID: 36959316 Free PMC article.

113

Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study.

Chang JI, Kim JH, Sinn DH, Cho JY, Kim KM, Oh JH, Park Y, Sohn W, Goh MJ, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Chang JI, et al. Among authors: gwak gy. Gut Liver. 2023 Jul 15;17(4):620-628. doi: 10.5009/gnl220420. Epub 2023 Mar 31. Gut Liver. 2023. PMID: 36999383 Free PMC article.

114

Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII.

Song BG, Goh MJ, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Paik SW, Sinn DH. Song BG, et al. Among authors: gwak gy. Liver Int. 2023 Sep;43(9):1966-1974. doi: 10.1111/liv.15632. Epub 2023 Jun 8. Liver Int. 2023. PMID: 37288716

115

Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B.

Oh JH, Park Y, Goh MJ, Sinn DH, Ahn SB, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Paik SW. Oh JH, et al. Among authors: gwak gy. Sci Rep. 2023 Jun 9;13(1):9443. doi: 10.1038/s41598-023-36668-2. Sci Rep. 2023. PMID: 37296217 Free PMC article.

116

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy.

Goh MJ, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Goh MJ, et al. Among authors: gwak gy. J Liver Cancer. 2020 Sep;20(2):160-166. doi: 10.17998/jlc.20.2.160. Epub 2020 Sep 30. J Liver Cancer. 2020. PMID: 37384324 Free PMC article.

117

Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B.

Park Y, Kang D, Sinn DH, Kim H, Hong YS, Cho J, Gwak GY. Park Y, et al. Among authors: gwak gy. World J Gastroenterol. 2023 Jun 28;29(24):3843-3854. doi: 10.3748/wjg.v29.i24.3843. World J Gastroenterol. 2023. PMID: 37426323 Free PMC article.

118

Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study.

Sinn DH, Kang D, Guallar E, Choi SC, Hong YS, Park Y, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. PLoS One. 2023 Jul 18;18(7):e0288820. doi: 10.1371/journal.pone.0288820. eCollection 2023. PLoS One. 2023. PMID: 37463179 Free PMC article.

119

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma.

Song BG, Choi SC, Goh MJ, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Paik SW. Song BG, et al. Among authors: gwak gy. JHEP Rep. 2023 Jun 28;5(9):100810. doi: 10.1016/j.jhepr.2023.100810. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37538246 Free PMC article.

120

Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data.

Sinn DH, Kang D, Park Y, Kim H, Hong YS, Cho J, Gwak GY. Sinn DH, et al. Among authors: gwak gy. BMC Gastroenterol. 2023 Oct 25;23(1):366. doi: 10.1186/s12876-023-02996-w. BMC Gastroenterol. 2023. PMID: 37880589 Free PMC article. Clinical Trial.

121

Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.

Goh MJ, Park HC, Yu JI, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Sinn DH, Choi MS. Goh MJ, et al. Among authors: gwak gy. Liver Cancer. 2023 Feb 10;12(5):467-478. doi: 10.1159/000529635. eCollection 2023 Oct. Liver Cancer. 2023. PMID: 37901765 Free PMC article.

122

Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score.

Kim A, Kang D, Choi SC, Cho J, Sinn DH, Gwak GY. Kim A, et al. Among authors: gwak gy. PLoS One. 2024 Mar 26;19(3):e0301126. doi: 10.1371/journal.pone.0301126. eCollection 2024. PLoS One. 2024. PMID: 38530817 Free PMC article.

123

Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis.

Kim A, Song BG, Kang W, Sinn DH, Gwak GY, Paik YH, Choi MS, Lee JH, Goh MJ. Kim A, et al. Among authors: gwak gy. Korean J Intern Med. 2024 May;39(3):448-457. doi: 10.3904/kjim.2023.354. Epub 2024 Apr 30. Korean J Intern Med. 2024. PMID: 38715233 Free PMC article.

124

Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.

Kim HJ, Cho JY, Kim YJ, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Kim HJ, et al. Among authors: gwak gy. Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30. Korean J Intern Med. 2015. PMID: 25589833 Free PMC article.

125

Predictors of the feasibility of primary endoscopic management of biliary strictures after adult living donor liver transplantation.

Lee YY, Gwak GY, Lee KH, Lee JK, Lee KT, Kwon CH, Joh JW, Lee SK. Lee YY, et al. Among authors: gwak gy. Liver Transpl. 2011 Dec;17(12):1467-73. doi: 10.1002/lt.22432. Liver Transpl. 2011. PMID: 21898773 Free article.

126

Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.

Cho JY, Paik YH, Lim HY, Kim YG, Lim HK, Min YW, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Cho JY, et al. Among authors: gwak gy. Liver Int. 2013 Jul;33(6):950-7. doi: 10.1111/liv.12168. Epub 2013 Apr 21. Liver Int. 2013. PMID: 23601249

127

Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.

Sohn W, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sohn W, et al. Among authors: gwak gy. Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19. Scand J Gastroenterol. 2014. PMID: 24354931

128

HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.

Sohn W, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sohn W, et al. Among authors: gwak gy. Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12. Ann Surg Oncol. 2014. PMID: 24619495

129

Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching.

Min YW, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS. Min YW, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504. J Gastroenterol Hepatol. 2014. PMID: 24863186

130

The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding.

Je D, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Je D, et al. Among authors: gwak gy. Clin Mol Hepatol. 2014 Sep;20(3):283-90. doi: 10.3350/cmh.2014.20.3.283. Epub 2014 Sep 25. Clin Mol Hepatol. 2014. PMID: 25320732 Free PMC article.

131

Enhanced resolution of eosinophilic liver abscess associated with toxocariasis by albendazole treatment.

Jang EY, Choi MS, Gwak GY, Koh KC, Paik SW, Lee JH, Paik YH, Yoo BC. Jang EY, et al. Among authors: gwak gy. Korean J Gastroenterol. 2015 Apr;65(4):222-8. doi: 10.4166/kjg.2015.65.4.222. Korean J Gastroenterol. 2015. PMID: 25896156 Free article.

132

Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.

Ahn JM, Paik YH, Lee JH, Cho JY, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Ahn JM, et al. Among authors: gwak gy. Clin Mol Hepatol. 2015 Dec;21(4):393-7. doi: 10.3350/cmh.2015.21.4.393. Epub 2015 Dec 24. Clin Mol Hepatol. 2015. PMID: 26770929 Free PMC article.

133

[Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation].

Oh SH, Lee JH, Hwang JW, Kim HY, Lee CH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC. Oh SH, et al. Among authors: gwak gy. Korean J Hepatol. 2009 Sep;15(3):362-9. doi: 10.3350/kjhep.2009.15.3.362. Korean J Hepatol. 2009. PMID: 19783886 Korean.

134

Clinical course of sub-centimeter-sized nodules detected during surveillance for hepatocellular carcinoma.

Min YW, Gwak GY, Lee MW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Min YW, et al. Among authors: gwak gy. World J Gastroenterol. 2012 Jun 7;18(21):2654-60. doi: 10.3748/wjg.v18.i21.2654. World J Gastroenterol. 2012. PMID: 22690074 Free PMC article.

135

Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.

Min YW, Kim J, Kim S, Sung YK, Lee JH, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Min YW, et al. Among authors: gwak gy. Liver Int. 2013 Feb;33(2):197-202. doi: 10.1111/liv.12023. Liver Int. 2013. PMID: 23295052

136

Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases.

Park JY, Choi MS, Lim YS, Park JW, Kim SU, Min YW, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Park JY, et al. Among authors: gwak gy. Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21. Gut Liver. 2014. PMID: 24516702 Free PMC article.

137

Factors Associated With Age-related Hearing Impairment: A Retrospective Cohort Study.

Moon IJ, Byun H, Woo SY, Gwak GY, Hong SH, Chung WH, Cho YS. Moon IJ, et al. Among authors: gwak gy. Medicine (Baltimore). 2015 Oct;94(43):e1846. doi: 10.1097/MD.0000000000001846. Medicine (Baltimore). 2015. PMID: 26512592 Free PMC article.

138

The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population.

Yang MH, Sung J, Gwak GY. Yang MH, et al. Among authors: gwak gy. J Clin Lipidol. 2016 Mar-Apr;10(2):289-98. doi: 10.1016/j.jacl.2015.11.017. Epub 2015 Dec 2. J Clin Lipidol. 2016. PMID: 27055959

139

Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?

Kim J, Sinn DH, Choi MS, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW. Kim J, et al. Among authors: gwak gy. PLoS One. 2019 Mar 7;14(3):e0213547. doi: 10.1371/journal.pone.0213547. eCollection 2019. PLoS One. 2019. PMID: 30845192 Free PMC article.

140

Clinical significance of core gene mutations during the course of genotype C chronic hepatitis B virus infection.

Lee DH, Gwak GY, Min BH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Lee DH, et al. Among authors: gwak gy. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1643-7. doi: 10.5754/hge08631. Hepatogastroenterology. 2011. PMID: 22086694

141

The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.

Lim DH, Lee H, Park HC, Lee JA, Kim SW, Yoo BC, Koh KC, Lee JH, Choi MS, Gwak GY, Paik SW. Lim DH, et al. Among authors: gwak gy. Am J Clin Oncol. 2013 Apr;36(2):162-6. doi: 10.1097/COC.0b013e3182438dae. Am J Clin Oncol. 2013. PMID: 22391433

142

A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease.

Min YW, Bae SY, Gwak GY, Paik YH, Choi MS, Lee JH, Paik SW, Yoo BC, Koh KC. Min YW, et al. Among authors: gwak gy. Clin Mol Hepatol. 2012 Jun;18(2):178-84. doi: 10.3350/cmh.2012.18.2.178. Epub 2012 Jun 26. Clin Mol Hepatol. 2012. PMID: 22893868 Free PMC article.

143

High-risk esophageal varices in patients treated with locoregional therapy for hepatocellular carcinoma: assessment with liver computed tomography.

Kim H, Choi D, Lee JH, Lee SJ, Jo H, Gwak GY, Koh KC, Choi MS, Kim S. Kim H, et al. Among authors: gwak gy. World J Gastroenterol. 2012 Sep 21;18(35):4905-11. doi: 10.3748/wjg.v18.i35.4905. World J Gastroenterol. 2012. PMID: 23002363 Free PMC article.

144

Role of radiofrequency ablation in patients with hepatocellular carcinoma who undergo prior transarterial chemoembolization: long-term outcomes and predictive factors.

Sohn W, Choi MS, Cho JY, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Sohn W, et al. Among authors: gwak gy. Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25. Gut Liver. 2014. PMID: 25071073 Free PMC article.

145

Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.

Ahn JM, Paik YH, Kim SH, Lee JH, Cho JY, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Ahn JM, et al. Among authors: gwak gy. J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30. J Korean Med Sci. 2014. PMID: 25120322 Free PMC article.

146

Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance.

Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, Gwak GY, Paik YH, Lim HY, Kim MJ. Kang TW, et al. Among authors: gwak gy. Radiology. 2015 Jul;276(1):274-85. doi: 10.1148/radiol.15141215. Epub 2015 Feb 25. Radiology. 2015. PMID: 25734550

147

[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Patients with Decompensated Cirrhosis].

Gwak GY. Gwak GY. Korean J Gastroenterol. 2016 Mar;67(3):137-41. doi: 10.4166/kjg.2016.67.3.137. Korean J Gastroenterol. 2016. PMID: 26996183 Free article. Korean.

148

Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response.

Cho JY, Sohn W, Sinn DH, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Cho JY, et al. Among authors: gwak gy. Korean J Intern Med. 2017 Jul;32(4):636-646. doi: 10.3904/kjim.2016.096. Epub 2016 Nov 4. Korean J Intern Med. 2017. PMID: 27809454 Free PMC article. Clinical Trial.

149

Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate.

Byun KS, Choi J, Kim JH, Lee YS, Lee HC, Kim YJ, Yoo BC, Kwon SY, Gwak GY, Lim YS. Byun KS, et al. Among authors: gwak gy. Clin Gastroenterol Hepatol. 2022 Feb;20(2):427-437.e5. doi: 10.1016/j.cgh.2021.04.045. Epub 2021 May 4. Clin Gastroenterol Hepatol. 2022. PMID: 33962041 Clinical Trial.

150

Clinical impact of the development of YMDD mutants in hepatitis B virus-associated glomerulonephritis.

Gwak GY, Lee CY, Lee DH, Huh W, Koh KC, Kim YG. Gwak GY, et al. Hepatogastroenterology. 2011 Jul-Aug;58(109):1291-5. doi: 10.5754/hge07389. Hepatogastroenterology. 2011. PMID: 21937397

151

Comparison of the Clinical Features of Hepatitis A between HBsAg-Positive and HBsAg-Negative Patients.

Kim KM, Eo SJ, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Kim KM, et al. Among authors: gwak gy. Gut Liver. 2011 Dec;5(4):500-5. doi: 10.5009/gnl.2011.5.4.500. Epub 2011 Nov 21. Gut Liver. 2011. PMID: 22195250 Free PMC article.

152

Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.

Lee JH, Lee JH, Lim YS, Yeon JE, Song TJ, Yu SJ, Gwak GY, Kim KM, Kim YJ, Lee JW, Yoon JH. Lee JH, et al. Among authors: gwak gy. Cancer Immunol Immunother. 2019 Jan;68(1):23-32. doi: 10.1007/s00262-018-2247-4. Epub 2018 Sep 19. Cancer Immunol Immunother. 2019. PMID: 30232520 Free PMC article.

153

[Role of hepatic stellate cells in the angiogenesis of hepatoma].

Jung JO, Gwak GY, Lim YS, Kim CY, Lee HS. Jung JO, et al. Among authors: gwak gy. Korean J Gastroenterol. 2003 Aug;42(2):142-8. Korean J Gastroenterol. 2003. PMID: 14532719 Korean.

154

Long-term survival after pulmonary metastatectomy of hepatocellular carcinoma; treatment outcome or natural history?

Gwak GY, Jung JO, Sung SW, Lee HS. Gwak GY, et al. Hepatogastroenterology. 2004 Sep-Oct;51(59):1428-33. Hepatogastroenterology. 2004. PMID: 15362769

155

Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells.

Yoon JH, Gwak GY, Lee HS, Bronk SF, Werneburg NW, Gores GJ. Yoon JH, et al. Among authors: gwak gy. J Hepatol. 2004 Nov;41(5):808-14. doi: 10.1016/j.jhep.2004.07.016. J Hepatol. 2004. PMID: 15519654

156

Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression.

Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ. Gwak GY, et al. J Hepatol. 2005 Mar;42(3):358-64. doi: 10.1016/j.jhep.2004.11.020. J Hepatol. 2005. PMID: 15710218

157

Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.

Kim TH, Kim KA, Lim YS, Gwak GY, Yoon JH, Kang GH, Lee HS. Kim TH, et al. Among authors: gwak gy. Intervirology. 2005;48(4):230-8. doi: 10.1159/000084600. Intervirology. 2005. PMID: 15920347 Clinical Trial.

158

Bile acid-mediated induction of cyclooxygenase-2 and Mcl-1 in hepatic stellate cells.

Kim KM, Yoon JH, Gwak GY, Kim W, Lee SH, Jang JJ, Lee HS. Kim KM, et al. Among authors: gwak gy. Biochem Biophys Res Commun. 2006 Apr 21;342(4):1108-13. doi: 10.1016/j.bbrc.2006.02.072. Epub 2006 Feb 21. Biochem Biophys Res Commun. 2006. PMID: 16513083

159

[A case of infiltrative hepatocellular carcinoma with main portal vein tumor thrombosis successfully treated by transarterial chemoembolization].

Myung SJ, Yoon JH, Gwak GY, Shin CM, Ahn DW, Yu SJ, Yu JW, Cho SJ, Chung JW, Lee HS. Myung SJ, et al. Among authors: gwak gy. Korean J Hepatol. 2006 Mar;12(1):107-11. Korean J Hepatol. 2006. PMID: 16565612 Korean.

160

Anti-apoptotic N-cadherin signaling and its prognostic implication in human hepatocellular carcinomas.

Gwak GY, Yoon JH, Yu SJ, Park SC, Jang JJ, Lee KB, Lee SH, Lee SM, Shin CS, Suh KS, Lee HS. Gwak GY, et al. Oncol Rep. 2006 May;15(5):1117-23. Oncol Rep. 2006. PMID: 16596172

161

Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments.

Myung SJ, Yoon JH, Kim KM, Gwak GY, Kim YJ, Yu JW, Chung JW, Lee HS. Myung SJ, et al. Among authors: gwak gy. Hepatogastroenterology. 2006 Mar-Apr;53(68):266-70. Hepatogastroenterology. 2006. PMID: 16608037

162

Eupatilin attenuates bile acid-induced hepatocyte apoptosis.

Park SC, Yoon JH, Kim W, Gwak GY, Kim KM, Lee SH, Lee SM, Lee HS. Park SC, et al. Among authors: gwak gy. J Gastroenterol. 2006 Aug;41(8):772-8. doi: 10.1007/s00535-006-1854-6. J Gastroenterol. 2006. PMID: 16988766

163

Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.

Myung SJ, Yoon JH, Gwak GY, Kim W, Yang JI, Lee SH, Jang JJ, Lee HS. Myung SJ, et al. Among authors: gwak gy. Biochem Biophys Res Commun. 2007 Feb 23;353(4):1091-6. doi: 10.1016/j.bbrc.2006.12.157. Epub 2006 Dec 28. Biochem Biophys Res Commun. 2007. PMID: 17204245

164

Analysis of the core gene of hepatitis B virus in Korean patients.

Kim HJ, Lee DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Kim HJ, et al. Among authors: gwak gy. Liver Int. 2007 Jun;27(5):633-8. doi: 10.1111/j.1478-3231.2007.01481.x. Liver Int. 2007. PMID: 17498248

165

Wnt signaling enhances the activation and survival of human hepatic stellate cells.

Myung SJ, Yoon JH, Gwak GY, Kim W, Lee JH, Kim KM, Shin CS, Jang JJ, Lee SH, Lee SM, Lee HS. Myung SJ, et al. Among authors: gwak gy. FEBS Lett. 2007 Jun 26;581(16):2954-8. doi: 10.1016/j.febslet.2007.05.050. Epub 2007 May 29. FEBS Lett. 2007. PMID: 17544413 Free article.

166

Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients.

Gwak GY, Kim TH, Yu SJ, Yoon JH, Yong JJ, Park SC, Lee HS. Gwak GY, et al. Hepatogastroenterology. 2007 Apr-May;54(75):844-8. Hepatogastroenterology. 2007. PMID: 17591076

167

Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes.

Yang JI, Yoon JH, Myung SJ, Gwak GY, Kim W, Chung GE, Lee SH, Lee SM, Kim CY, Lee HS. Yang JI, et al. Among authors: gwak gy. Biochem Biophys Res Commun. 2007 Sep 14;361(1):156-61. doi: 10.1016/j.bbrc.2007.07.001. Epub 2007 Jul 19. Biochem Biophys Res Commun. 2007. PMID: 17659258

168

[Changes in the profiles of causative agents and antibiotic resistance rate for spontaneous bacterial peritonitis: an analysis of cultured microorganisms in recent 12 years].

Park MK, Lee JH, Byun YH, Lee HIe, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Rhee JC. Park MK, et al. Among authors: gwak gy. Korean J Hepatol. 2007 Sep;13(3):370-7. doi: 10.3350/kjhep.2007.13.3.370. Korean J Hepatol. 2007. PMID: 17898553 Korean.

169

[A case of solitary fibrous tumor of the liver].

Kwak SY, Gwak GY, Yun WK, Kim HJ, Do IG, Joh JW, Park CK. Kwak SY, et al. Among authors: gwak gy. Korean J Hepatol. 2007 Dec;13(4):560-4. doi: 10.3350/kjhep.2007.13.4.560. Korean J Hepatol. 2007. PMID: 18159154 Korean.

170

Successful treatment for hepatocellular carcinoma with main portal vein tumor thrombi by 3-dimensional conformal radiation therapy combined with transarterial chemoembolization.

Gwak GY, Yoon JH, Chie EK, Chung JW, Lee HS. Gwak GY, et al. Hepatogastroenterology. 2008 Mar-Apr;55(82-83):673-6. Hepatogastroenterology. 2008. PMID: 18613431

171

High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT.

Kim H, Choi D, Gwak GY, Lee JH, Lee SJ, Kim SH, Lee JY, Park Y, Chang I, Lim HK. Kim H, et al. Among authors: gwak gy. Dig Dis Sci. 2009 Oct;54(10):2247-52. doi: 10.1007/s10620-008-0606-2. Epub 2008 Dec 3. Dig Dis Sci. 2009. PMID: 19051016

172

Occult hepatitis B virus infection in chronic hemodialysis patients in Korea.

Gwak GY, Huh W, Lee DH, Min BH, Koh KC, Kim JJ, Oh HY. Gwak GY, et al. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1721-4. Hepatogastroenterology. 2008. PMID: 19102377

173

The correlation of hepatitis B virus pre-S mutation with cellular oxidative DNA damage in hepatocellular carcinoma.

Gwak GY, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Park CK, Joh JW, Yoo BC. Gwak GY, et al. Hepatogastroenterology. 2008 Nov-Dec;55(88):2028-32. Hepatogastroenterology. 2008. PMID: 19260471

174

Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses of the performance of radiologists and endoscopists.

Kim H, Choi D, Gwak GY, Lee JH, Park MK, Lee HIe, Kim SH, Nam S, Yoo EY, Do YS. Kim H, et al. Among authors: gwak gy. J Gastroenterol Hepatol. 2009 Sep;24(9):1534-40. doi: 10.1111/j.1440-1746.2009.05849.x. Epub 2009 Apr 13. J Gastroenterol Hepatol. 2009. PMID: 19486446

175

The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.

Han AR, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Han AR, et al. Among authors: gwak gy. Hepatogastroenterology. 2009 Jul-Aug;56(93):1111-6. Hepatogastroenterology. 2009. PMID: 19760952

176

Long-term treatment outcomes for autoimmune hepatitis in Korea.

Kil JS, Lee JH, Han AR, Kang JY, Won HJ, Jung HY, Lim HM, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC. Kil JS, et al. Among authors: gwak gy. J Korean Med Sci. 2010 Jan;25(1):54-60. doi: 10.3346/jkms.2010.25.1.54. Epub 2009 Dec 29. J Korean Med Sci. 2010. PMID: 20052348 Free PMC article.

177

Prediction of complete necrosis of hepatocellular carcinoma treated with transarterial chemoembolization prior to liver transplantation.

Kim SJ, Choi MS, Kang JY, Choi DI, Park CK, Gwak GY, Lee JH, Koh KC, Paik SW, Yoo BC. Kim SJ, et al. Among authors: gwak gy. Gut Liver. 2009 Dec;3(4):285-91. doi: 10.5009/gnl.2009.3.4.285. Epub 2009 Dec 31. Gut Liver. 2009. PMID: 20431762 Free PMC article.

178

The efficacy of combined transarterial chemoembolization and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosis.

Park MK, Gwak GY, Lim DH, Choo SW, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Park MK, et al. Among authors: gwak gy. Hepatogastroenterology. 2010 Jul-Aug;57(101):801-6. Hepatogastroenterology. 2010. PMID: 21033233

179

A low viral load predicts a higher initial virologic response to adefovir in patients with Lamivudine-resistant chronic hepatitis B.

Shin SR, Koh KC, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC. Shin SR, et al. Among authors: gwak gy. Gut Liver. 2010 Dec;4(4):530-6. doi: 10.5009/gnl.2010.4.4.530. Epub 2010 Dec 17. Gut Liver. 2010. PMID: 21253304 Free PMC article.

180

Antiviral therapy in patients after treatment for hepatitis C-related hepatocellular carcinoma.

Shin SR, Paik SW, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC. Shin SR, et al. Among authors: gwak gy. Gut Liver. 2011 Mar;5(1):77-81. doi: 10.5009/gnl.2011.5.1.77. Epub 2011 Mar 16. Gut Liver. 2011. PMID: 21461077 Free PMC article.

181

The correlation of hepatitis B virus pre-S mutation with mitochondrial D-loop mutations and common deletions in hepatocellular carcinoma.

Gwak GY, Lee DH, Moon TG, Choi MS, Lee JH, Koh KC, Paik SW, Joh JW, Yoo BC. Gwak GY, et al. Hepatogastroenterology. 2011 Mar-Apr;58(106):522-8. Hepatogastroenterology. 2011. PMID: 21661424

182

Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway.

Gwak GY, Moon TG, Lee DH, Yoo BC. Gwak GY, et al. World J Gastroenterol. 2012 Feb 21;18(7):679-84. doi: 10.3748/wjg.v18.i7.679. World J Gastroenterol. 2012. PMID: 22363140 Free PMC article.

183

Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area.

Bae SY, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC. Bae SY, et al. Among authors: gwak gy. Clin Mol Hepatol. 2012 Jun;18(2):185-94. doi: 10.3350/cmh.2012.18.2.185. Epub 2012 Jun 26. Clin Mol Hepatol. 2012. PMID: 22893869 Free PMC article.

184

Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors.

Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC. Kim YS, et al. Among authors: gwak gy. J Hepatol. 2013 Jan;58(1):89-97. doi: 10.1016/j.jhep.2012.09.020. Epub 2012 Sep 27. J Hepatol. 2013. PMID: 23023009

185

A case of nonalcoholic steatohepatitis and small intestinal bacterial overgrowth with peripheral edema caused by intestinal bypass surgery and relieved by repair.

Sung YK, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Sung YK, et al. Among authors: gwak gy. Gut Liver. 2012 Oct;6(4):520-3. doi: 10.5009/gnl.2012.6.4.520. Epub 2012 Oct 18. Gut Liver. 2012. PMID: 23170161 Free PMC article.

186

Pegylated interferon and ribavirin in the retreatment of chronic hepatitis C in Korea.

Cho HC, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW. Cho HC, et al. Among authors: gwak gy. Gut Liver. 2013 Sep;7(5):585-93. doi: 10.5009/gnl.2013.7.5.585. Epub 2013 Aug 14. Gut Liver. 2013. PMID: 24073317 Free PMC article.

187

The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma.

Cho JY, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Cho JY, et al. Among authors: gwak gy. Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12. Liver Int. 2014. PMID: 24350564 Clinical Trial.

188

Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma.

Kim SW, Oh D, Park HC, Lim DH, Shin SW, Cho SK, Gwak GY, Choi MS, Paik YH, Paik SW. Kim SW, et al. Among authors: gwak gy. Radiat Oncol J. 2014 Mar;32(1):14-22. doi: 10.3857/roj.2014.32.1.14. Epub 2014 Mar 27. Radiat Oncol J. 2014. PMID: 24724047 Free PMC article.

189

Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.

Kim E, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Kim E, et al. Among authors: gwak gy. Hepatogastroenterology. 2014 Sep;61(134):1704-11. Hepatogastroenterology. 2014. PMID: 25436366

190

Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications.

Yu JI, Cho JY, Park HC, Lim DH, Gwak GY, Paik SW. Yu JI, et al. Among authors: gwak gy. Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270. Tumori. 2014. PMID: 25688498

191

Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.

Lee JH, Lee JH, Lim YS, Yeon JE, Song TJ, Yu SJ, Gwak GY, Kim KM, Kim YJ, Lee JW, Yoon JH. Lee JH, et al. Among authors: gwak gy. Gastroenterology. 2015 Jun;148(7):1383-91.e6. doi: 10.1053/j.gastro.2015.02.055. Epub 2015 Mar 4. Gastroenterology. 2015. PMID: 25747273 Free article. Clinical Trial.

192

Renal outcomes after liver transplantation in fulminant hepatitis A with acute kidney injury: comparison with hepatorenal syndrome.

Park JY, Gwak GY, Kim JM, Oh HJ, Yi NJ, Suh KS, Kim DK, Lim CS, Kim YS, Lee JP. Park JY, et al. Among authors: gwak gy. Transplant Proc. 2015 Apr;47(3):709-17. doi: 10.1016/j.transproceed.2014.10.057. Transplant Proc. 2015. PMID: 25891716

193

A comparison of clevudine and entecavir for treatment-naïve patients with chronic hepatitis B: results after 2 years of treatment.

Gwak GY, Eo SJ, Shin SR, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Gwak GY, et al. Hepatol Int. 2013 Mar;7(1):106-10. doi: 10.1007/s12072-012-9368-1. Epub 2012 Apr 24. Hepatol Int. 2013. PMID: 26201625

194

Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents.

Shin JH, Kwon HJ, Jang HR, Lee JE, Gwak GY, Huh W, Jung SH, Lee JH, Kim YG, Kim DJ, Oh HY. Shin JH, et al. Among authors: gwak gy. Medicine (Baltimore). 2016 Jan;95(1):e2400. doi: 10.1097/MD.0000000000002400. Medicine (Baltimore). 2016. PMID: 26735542 Free PMC article.

195

Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.

Kang TW, Rhim H, Lee J, Song KD, Lee MW, Kim YS, Lim HK, Jang KM, Kim SH, Gwak GY, Jung SH. Kang TW, et al. Among authors: gwak gy. Eur Radiol. 2016 Oct;26(10):3437-46. doi: 10.1007/s00330-015-4190-5. Epub 2016 Jan 8. Eur Radiol. 2016. PMID: 26747262

196

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

Cho YY, Lee M, Kim HC, Chung JW, Kim YH, Gwak GY, Bae SH, Kim do Y, Heo J, Kim YJ. Cho YY, et al. Among authors: gwak gy. PLoS One. 2016 May 5;11(5):e0154986. doi: 10.1371/journal.pone.0154986. eCollection 2016. PLoS One. 2016. PMID: 27149067 Free PMC article.

197

The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma.

Kim JH, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Kim JH, et al. Among authors: gwak gy. Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666. Medicine (Baltimore). 2016. PMID: 28002336 Free PMC article.

198

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.

Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW. Cho JY, et al. Among authors: gwak gy. Clin Mol Hepatol. 2016 Dec;22(4):477-486. doi: 10.3350/cmh.2016.0048. Epub 2016 Dec 25. Clin Mol Hepatol. 2016. PMID: 28081587 Free PMC article.

199

Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.

Lim YS, Lee YS, Gwak GY, Byun KS, Kim YJ, Choi J, An J, Lee HC, Yoo BC, Kwon SY. Lim YS, et al. Among authors: gwak gy. Hepatology. 2017 Sep;66(3):772-783. doi: 10.1002/hep.29187. Epub 2017 Jul 18. Hepatology. 2017. PMID: 28370419

200

Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.

Lee MW, Lim HK, Rhim H, Cha DI, Kang TW, Song KD, Min JH, Gwak GY, Kim S, Lu DSK. Lee MW, et al. Among authors: gwak gy. Can J Gastroenterol Hepatol. 2018 Jun 14;2018:7926923. doi: 10.1155/2018/7926923. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30013957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page